6xxv
From Proteopedia
(Difference between revisions)
(One intermediate revision not shown.) | |||
Line 3: | Line 3: | ||
<StructureSection load='6xxv' size='340' side='right'caption='[[6xxv]], [[Resolution|resolution]] 2.20Å' scene=''> | <StructureSection load='6xxv' size='340' side='right'caption='[[6xxv]], [[Resolution|resolution]] 2.20Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'> | + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6XXV OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6XXV FirstGlance]. <br> |
- | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2011642Å</td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6xxv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6xxv OCA], [https://pdbe.org/6xxv PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6xxv RCSB], [https://www.ebi.ac.uk/pdbsum/6xxv PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6xxv ProSAT]</span></td></tr> |
</table> | </table> | ||
- | <div style="background-color:#fffaf0;"> | ||
- | == Publication Abstract from PubMed == | ||
- | De novo protein design has been successful in expanding the natural protein repertoire. However, most de novo proteins lack biological function, presenting a major methodological challenge. In vaccinology, the induction of precise antibody responses remains a cornerstone for next-generation vaccines. Here, we present a protein design algorithm called TopoBuilder, with which we engineered epitope-focused immunogens displaying complex structural motifs. In both mice and nonhuman primates, cocktails of three de novo-designed immunogens induced robust neutralizing responses against the respiratory syncytial virus. Furthermore, the immunogens refocused preexisting antibody responses toward defined neutralization epitopes. Overall, our design approach opens the possibility of targeting specific epitopes for the development of vaccines and therapeutic antibodies and, more generally, will be applicable to the design of de novo proteins displaying complex functional motifs. | ||
- | + | ==See Also== | |
- | + | *[[Antibody 3D structures|Antibody 3D structures]] | |
- | + | *[[3D structures of human antibody|3D structures of human antibody]] | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: Human]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Correia | + | [[Category: Correia BE]] |
- | [[Category: Pojer | + | [[Category: Pojer F]] |
- | [[Category: Sesterhenn | + | [[Category: Sesterhenn F]] |
- | [[Category: Yang | + | [[Category: Yang C]] |
- | + | ||
- | + | ||
- | + | ||
- | + |
Current revision
Crystal Structure of a computationally designed Immunogen S2_1.2 in complex with its elicited antibody C57
|